Friday, February 26, 2021

F.D.A. Expert Panel Endorses Johnson & Johnson’s Vaccine


By BY CARL ZIMMER AND NOAH WEILAND from NYT Health https://ift.tt/3aXBwTO
>

No comments:

Post a Comment

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...